Authors of the clinical advice, published in the Canadian Medical Association Journal, say that medications and surgery should be offered with nutrition, exercise and psychological support

New medical guideline features 10 recommendations, including one in favour of GLP-1 receptor agonists, the class of drugs that contains semaglutide, better known as the Type 2 diabetes medication Ozempic. Boxes of Ozempic and Wegovy are seen at a pharmacy in London, England, on March 8, 2024.

Doctors caring for young people with obesity should provide nutritionaland exercise advice, but should also consider offering weight-loss drugs and bariatric surgery to teenagers, according to the first new Canadian guideline on the treatment of pediatric obesity in nearly 20 years.

The clinical practice guideline, which provides advice to doctors on how to treat children with obesity, was published Monday in the Canadian Medical Association Journal. It features 10 recommendations, including one in favour of GLP-1 receptor agonists, the class of drugs that contains semaglutide, better known as the Type 2 diabetes medication Ozempic.

From The Globe and Mail via this RSS feed